- ASGO 7th International Workshop on Gynecologic Oncology
-
Yang J, Xiang Y, Kong B
- KMID: 2537973
- J Gynecol Oncol.
- 2022 Nov;33(6):e85.
- doi: 10.3802/jgo.2022.33.e85
-
- CITED
-
- Close
- SHARE
-
- Close
- Overview of fuzuloparib in the treatment of ovarian cancer: background and future perspective
-
Li N, Liu Q, Tian Y, Wu L
- KMID: 2537974
- J Gynecol Oncol.
- 2022 Nov;33(6):e86.
- doi: 10.3802/jgo.2022.33.e86
Over the last decade, clinical trials using various poly ADP ribose polymerase (PARP) inhibitors on patients with ovarian cancer have shown promising results. The introduction of PARP inhibitors has changed... -
- CITED
-
- Close
- SHARE
-
- Close
- The impact of interval between primary cytoreductive surgery with bowel resection and initiation of adjuvant chemotherapy on survival of women with advanced ovarian cancer: a multicenter cohort study
-
Lee YY, Kim SR, Kollara A, Brown T, May T
- KMID: 2537967
- J Gynecol Oncol.
- 2022 Nov;33(6):e76.
- doi: 10.3802/jgo.2022.33.e76
Objective Our aim was to determine if the time interval between bowel resection and initiation of adjuvant chemotherapy impacts survival in advanced ovarian cancers. Methods This was a retrospective cohort study using data... -
- CITED
-
- Close
- SHARE
-
- Close
- Randomized comparison between sentinel lymph node mapping using indocyanine green plus a fluorescent camera versus lymph node dissection in clinical stage I-II endometrial cancer: a Korean Gynecologic Oncology Group trial (KGOG2029/SELYE)
-
Park JY, Kim JH, Baek MH, Park E, Kim SW
- KMID: 2537972
- J Gynecol Oncol.
- 2022 Nov;33(6):e73.
- doi: 10.3802/jgo.2022.33.e73
Background Sentinel lymph node (SLN) mapping has been suggested as an alternative surgical technique to full lymphadenectomy for early-stage endometrial cancer. However, the survival outcomes of SLN mapping compared with lymphadenectomy... -
- CITED
-
- Close
- SHARE
-
- Close
- Predicting prognosis according to the updated WHO classification in patients with endocervical adenocarcinoma treated with surgery and radiotherapy
-
Cho WK, Kim HS, Park W, Chang CS, Lee YY, Choi CH, Kim TJ, Lee JW, Kim BG
- KMID: 2537962
- J Gynecol Oncol.
- 2022 Nov;33(6):e71.
- doi: 10.3802/jgo.2022.33.e71
Objective The recently updated World Health Organization classification divides endocervical adenocarcinomas (ADCs) into human papillomavirus (HPV)-associated (HPVA) and HPV-independent (HPVI) ADCs. This study aimed to investigate the differences in the clinical... -
- CITED
-
- Close
- SHARE
-
- Close
- High expression of folate receptor alpha is associated with poor prognosis in patients with cervical cancer
-
Yazaki S, Kojima Y, Yoshida H, Takamizawa S, Kitadai R, Nishikawa T, Shimoi T, Sudo K, Saito A, Okuma HS, Tanioka M, Noguchi E, Uno M, Ishikawa M, Kato T, Fujiwara Y, Ohe Y, Yonemori K
- KMID: 2537963
- J Gynecol Oncol.
- 2022 Nov;33(6):e82.
- doi: 10.3802/jgo.2022.33.e82
Objective Folate receptor α (FRα) is a membrane protein expressed in various solid tumors but has limited expression in normal cells. Therefore, FRα is an attractive target for cancer treatment. This... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic influence of an early time to chemotherapy following primary cytoreductive surgery for advanced epithelial ovarian cancer
-
Eisenkop SM, Okabe H
- KMID: 2537970
- J Gynecol Oncol.
- 2022 Nov;33(6):e80.
- doi: 10.3802/jgo.2022.33.e80
Objective The current investigation analyzes the prognostic role of the time to chemotherapy (TTC) interval following primary cytoreductive surgery for patients with advanced epithelial ovarian cancer. Methods Characteristics and outcome data for 509... -
- CITED
-
- Close
- SHARE
-
- Close
- Epidemiologic study on gestational trophoblastic diseases in Japan
-
Yamamoto E, Nishino K, Niimi K, Ino K
- KMID: 2537964
- J Gynecol Oncol.
- 2022 Nov;33(6):e72.
- doi: 10.3802/jgo.2022.33.e72
Objective This study aims to estimate the population-based incidence of gestational trophoblastic diseases (GTDs) and to identify the characteristics of gestational trophoblastic neoplasia (GTN) in Japan. Methods The annual number of GTD and... -
- CITED
-
- Close
- SHARE
-
- Close
- SP1-induced lncRNA MCF2L-AS1 promotes cisplatin resistance in ovarian cancer by regulating IGF2BP1/IGF2/MEK/ERK axis
-
Zhu Y, Yang L, Wang J, Li Y, Chen Y
- KMID: 2537966
- J Gynecol Oncol.
- 2022 Nov;33(6):e75.
- doi: 10.3802/jgo.2022.33.e75
Objective Cisplatin resistance is a huge problem encountered in ovarian cancer treatment. Our study probed the roles and the underlying mechanisms of lncRNA MCF2L-AS1 in ovarian cancer cisplatin-resistance. Methods SKOV3 and IGROV-1 cells... -
- CITED
-
- Close
- SHARE
-
- Close
- Immunonutrition in ovarian cancer: clinical and immunological impact?
-
Ferrero A, Vassallo D, Geuna M, Fuso L, Villa M, Badellino E, Barboni M, Coata P, Santoro N, Bolton RCD, Biglia N
- KMID: 2537968
- J Gynecol Oncol.
- 2022 Nov;33(6):e77.
- doi: 10.3802/jgo.2022.33.e77
Objective Malnutrition is frequent in ovarian cancer (OC) patients and may compromise post-operative outcomes. The aim of this study is to evaluate the impact of pre-operative immunonutrition on the surgical outcome... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostication of early-onset endometrioid endometrial cancer based on genome-wide DNA methylation profiles
-
Hirano T, Arai E, Fujimoto M, Nakayama Y, Tian Y, Ito N, Makabe T, Yamagami W, Susumu N, Aoki D, Kanai Y
- KMID: 2537965
- J Gynecol Oncol.
- 2022 Nov;33(6):e74.
- doi: 10.3802/jgo.2022.33.e74
Objective The aim of this study was to establish criteria that would indicate whether fertility preservation therapy would likely be safe for patients aged 40 years or less with endometrioid endometrial... -
- CITED
-
- Close
- SHARE
-
- Close
- LncRNA XIST promotes carboplatin resistance of ovarian cancer through activating autophagy via targeting miR-506-3p/FOXP1 axis
-
Xia X, Li Z, Li Y, Ye F, Zhou X
- KMID: 2537971
- J Gynecol Oncol.
- 2022 Nov;33(6):e81.
- doi: 10.3802/jgo.2022.33.e81
Objective Resistance to chemotherapy drugs makes ovarian cancer (OC) difficult to treat and ultimately kills patients. Long non-coding RNAs are closely related to carboplatin resistance in OC. In present study, we... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidence of gastrointestinal perforation associated with bevacizumab in combination with neoadjuvant chemotherapy as first-line treatment of advanced ovarian, fallopian tube, or peritoneal cancer: analysis of a Japanese healthcare claims database
-
Ueda A, Watari H, Mandai M, Fukuhara S, Sugitani Y, Ogino K, Kamijima S, Enomoto T
- KMID: 2537969
- J Gynecol Oncol.
- 2022 Nov;33(6):e78.
- doi: 10.3802/jgo.2022.33.e78
Objective To assess the incidence of bevacizumab-associated gastrointestinal (GI) perforation during first-line treatment of patients with ovarian, fallopian tube, or peritoneal cancer receiving neoadjuvant chemotherapy (NAC) in Japanese real-world clinical practice. Methods A... -
- CITED
-
- Close
- SHARE
-
- Close
